Azithromycin

Half-Life (t½)
PO: 41h · IV: 41h
Formula
C38H72N2O12
Molecular Weight
748.98 g/mol
PubChem CID
447043
Aliases
Zithromax, Z-pak

Pharmacological Mechanism

Azalide macrolide — 50S ribosomal inhibitor; expanded gram-negative + atypical coverage vs erythromycin. Long tissue half-life supports 5-day dosing. Modest CYP3A4 inhibition (less than erythromycin/clarithromycin). QT prolongation signal at high doses.

Half-Life & Elimination Curve (PO: 41h · IV: 41h)

100%50%25%12.5%0%0h0×t½41h1×t½3.4d2×t½5.1d3×t½6.8d4×t½8.5d5×t½0×t½ (0h): 100% remaining (~76.7 µg/L)1×t½ (41h): 50% remaining (~38.4 µg/L)2×t½ (3.4d): 25% remaining (~19.2 µg/L)3×t½ (5.1d): 12.5% remaining (~9.59 µg/L)4×t½ (6.8d): 6.3% remaining (~4.79 µg/L)5×t½ (8.5d): 3.1% remaining (~2.4 µg/L)
Plasma (PO)t½ Decay (41h)
  • 0×t½0h100% (76.7 µg/L)
  • 1×t½41h50% (38.4 µg/L)
  • 2×t½3.4d25% (19.2 µg/L)
  • 3×t½5.1d12.5% (9.59 µg/L)
  • 4×t½6.8d6.3% (4.79 µg/L)
  • 5×t½8.5d3.1% (2.4 µg/L)
Elimination t½41h (PO)
Rate Constant (ke)0.0169 h⁻¹
Time to Peak (Tmax)7.01h
Est. Peak (Cmax)76.7 µg/L
Clearance (CL)37.2 L/h
97% Washout (5×t½)8.5d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References